Search research articles
Contact Us
Filters
Showing results (161-170 of 611) with videos related to
Page
of 62
Sort By:
Brain : a Journal of Neurology
|
April 1, 1989
Lateral visually-guided saccades in progressive supranuclear palsy
C Pierrot-Deseilligny, S Rivaud, B Pillon, et al.
Journal of Receptor Research
|
January 1, 1987
Pitfalls in membrane binding sites studies in post-mortem human brain
R Cash, R Raisman, P Cervera, et al.
Lancet (London, England)
|
September 18, 1997
Tolcapone, bromocriptine, and Parkinson's disease. French Tolcapone Study Group
Y Agid, A Destée, F Durif, et al.
Neurology
|
August 1, 1984
Low-dose CU 32-085 (mesulergine) in previously untreated Parkinson's disease
A M Bonnet, M Esteguy, J Guimaraes, et al.
Brain Research
|
September 26, 1983
Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease
B Scatton, F Javoy-Agid, L Rouquier, et al.
Neuroreport
|
March 3, 1997
Absence of neurotoxicity of chronic L-DOPA in 6-hydroxydopamine-lesioned rats
G Dziewczapolski, G Murer, Y Agid, et al.
Neurology
|
November 1, 1990
Catecholaminergic systems in the medulla oblongata in parkinsonian syndromes: a quantitative immunohistochemical study in Parkinson's disease, progressive supranuclear palsy, and striatonigral degeneration
S Malessa, E C Hirsch, P Cervera, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 24, 1999
The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease
M Vidailhet, A M Bonnet, R Marconi, et al.
The European Journal of Neuroscience
|
April 1, 1994
Morphological and molecular characterization of the response of differentiated PC12 cells to calcium stress
P P Michel, S Vyas, P Anglade, et al.
Neurology
|
December 1, 1994
Down's syndrome and Parkinson's disease
J P Brandel, R Marconi, M Serdaru, et al.
Page
of 62
Search research articles
Search
Showing results (161-170 of 611) with videos related to
Sort By:
Page
of 62
Brain : a Journal of Neurology
|
April 1, 1989
Lateral visually-guided saccades in progressive supranuclear palsy
C Pierrot-Deseilligny, S Rivaud, B Pillon, et al.
Journal of Receptor Research
|
January 1, 1987
Pitfalls in membrane binding sites studies in post-mortem human brain
R Cash, R Raisman, P Cervera, et al.
Lancet (London, England)
|
September 18, 1997
Tolcapone, bromocriptine, and Parkinson's disease. French Tolcapone Study Group
Y Agid, A Destée, F Durif, et al.
Neurology
|
August 1, 1984
Low-dose CU 32-085 (mesulergine) in previously untreated Parkinson's disease
A M Bonnet, M Esteguy, J Guimaraes, et al.
Brain Research
|
September 26, 1983
Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease
B Scatton, F Javoy-Agid, L Rouquier, et al.
Neuroreport
|
March 3, 1997
Absence of neurotoxicity of chronic L-DOPA in 6-hydroxydopamine-lesioned rats
G Dziewczapolski, G Murer, Y Agid, et al.
Neurology
|
November 1, 1990
Catecholaminergic systems in the medulla oblongata in parkinsonian syndromes: a quantitative immunohistochemical study in Parkinson's disease, progressive supranuclear palsy, and striatonigral degeneration
S Malessa, E C Hirsch, P Cervera, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 24, 1999
The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease
M Vidailhet, A M Bonnet, R Marconi, et al.
The European Journal of Neuroscience
|
April 1, 1994
Morphological and molecular characterization of the response of differentiated PC12 cells to calcium stress
P P Michel, S Vyas, P Anglade, et al.
Neurology
|
December 1, 1994
Down's syndrome and Parkinson's disease
J P Brandel, R Marconi, M Serdaru, et al.
Page
of 62